Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".

Ortega-Paz, Luis

Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial". [electronic resource] - Circulation 04 2020 - e748-e749 p. digital

Publication Type: Letter; Comment

1524-4539

10.1161/CIRCULATIONAHA.120.045964 doi


Drug-Eluting Stents
Everolimus
Humans
Magnesium
ST Elevation Myocardial Infarction--diagnosis
Sirolimus--adverse effects